Related Experiment Video
Updated: Jul 6, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis
Kaori Ishikawa1, Keizo Takenaga, Miho Akimoto
1Graduate School of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8572, Japan.
Abstract:
Mutations in mitochondrial DNA (mtDNA) occur at high frequency in human tumors, but whether these mutations alter tumor cell behavior has been unclear. We used cytoplasmic hybrid (cybrid) technology to replace the endogenous mtDNA in a mouse tumor cell line that was poorly metastatic with mtDNA from a cell line that was highly metastatic, and vice versa. Using assays of metastasis in mice, we found that the recipient tumor cells acquired the metastatic potential of the transferred mtDNA. The mtDNA conferring high metastatic potential contained G13997A and 13885insC mutations in the gene encoding NADH (reduced form of nicotinamide adenine dinucleotide) dehydrogenase subunit 6 (ND6). These mutations produced a deficiency in respiratory complex I activity and were associated with overproduction of reactive oxygen species (ROS). Pretreatment of the highly metastatic tumor cells with ROS scavengers suppressed their metastatic potential in mice. These results indicate that mtDNA mutations can contribute to tumor progression by enhancing the metastatic potential of tumor cells.
Insights
Mitochondrial DNA (mtDNA) mutations in cancer cells can enhance their ability to metastasize. Replacing mtDNA between cell lines showed that specific mutations in the ND6 gene increased tumor cell metastatic potential by affecting respiration and reactive oxygen species (ROS) production.
Area of Science:
- Cancer Biology
- Mitochondrial Genetics
- Tumor Metastasis
Background:
- Mitochondrial DNA (mtDNA) mutations are frequent in human tumors.
- The functional impact of mtDNA mutations on tumor cell behavior, particularly metastasis, remains largely unclear.
Purpose of the Study:
- To investigate whether mtDNA mutations influence the metastatic potential of tumor cells.
- To determine if specific mtDNA mutations can confer or suppress metastatic ability.
Main Methods:
- Utilized cytoplasmic hybrid (cybrid) technology to exchange mtDNA between poorly and highly metastatic mouse tumor cell lines.
- Assessed metastasis in vivo in mice following mtDNA transfer.
- Analyzed specific mtDNA mutations (G13997A and 13885insC in ND6 gene) and their effect on respiratory complex I activity and reactive oxygen species (ROS) production.
Main Results:
- Tumor cells acquired the metastatic potential of the transferred mtDNA.
- mtDNA conferring high metastatic potential harbored G13997A and 13885insC mutations in the ND6 gene.
- These mutations led to respiratory complex I deficiency and increased ROS production, which was linked to enhanced metastasis.
Conclusions:
- mtDNA mutations can significantly contribute to tumor progression by enhancing metastatic potential.
- Specific mtDNA mutations affecting cellular respiration and ROS levels are key drivers of cancer metastasis.
- Targeting ROS may represent a therapeutic strategy to inhibit mtDNA-driven tumor cell metastasis.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
Abnormal Proliferation
Replicative Cell Senescence
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
